DocWire News Editors

DocwireNews

InSilixa, a biotech company based in Sunnyvale, California, has recently developed a portable device that can identify microbes present in your body in a matter of hours. The system utilizes a high-performance biosensor created with the company’s innovative complementary metal-oxide semiconductor (CMOS) processes, and can identify various genetic components, protein fragments, and metabolites from pathogens to diagnose diseases. This device can rapidly identify resistant bacteria and allow doctors to immediately prescribe proper medication, reducing overuse of antibiotics and development of drug resistance. Being that the number of drug-resistant bacteria is growing, InSilixa’s product is a potential solution to this crisis.<img loading="lazy" decoding="async" class="wp-image-4766797 alignright" src="https://mumcdnstorage.blob.core.windows.net/dwnews/2018/07/cmos_biochip_module1.jpg" alt="" width="286" height="309">
The current system in place for physicians to identify microbes by genetic material often involves a culturing process that can take up to weeks, creating either a delay in infection treatment or causing the physician to make an educated guess on how to treat the patient. With InSilixa’s new biochip, physicians would be able to scan a patient for microbes in under 2 hours, with no culturing required. A patient sample, such as blood or a cheek swab, is simply loaded onto a reader which then conducts 5 processes to isolate and compare genetic material to that of known pathogens.
In their study published in Nature Biotechnology, the researchers claimed that their technology can identify specific mutations for antibiotic resistance in 7 different species of microbes in one run. The developers believe they will eventually be able to identify up to 100 microbes at one time. They also detected 54 mutations associated with drug resistance in 6 genes of Mycobacterium tuberculosis. The team also intends to create an open platform that allows physicians to create chips customized to scan for microbes specific to their geographic area.
<iframe loading="lazy" src="https://www.youtube.com/embed/3icgDvXu1vA" width="640" height="360" frameborder="0" allowfullscreen="allowfullscreen"></iframe> 
Sources: <a href="http://www.sciencemag.org/news/2018/07/chip-can-quickly-identify-microbes-living-your-body">Science Mag</a>, <a href="https://www.nature.com/articles/Nbt.4179">Nature</a>, <a href="http://www.insilixa.com/technology/cmos-biochips/">InSilixa</a>

InSilixa, a biotech company based in Sunnyvale, California, has recently developed a portable device that can identify microbes present in your body in a matter of hours. The system utilizes a high-performance biosensor created with the company’s innovative complementary metal-oxide semiconductor (CMOS) processes, and can identify various genetic components, protein fragments, and metabolites from pathogens to diagnose diseases. This device can rapidly identify resistant bacteria and allow doctors to immediately prescribe proper medication, reducing overuse of antibiotics and development of drug resistance. Being that the number of drug-resistant bacteria is growing, InSilixa’s product is a potential solution to this crisis.<img loading="lazy" decoding="async" class="wp-image-4766797 alignright" src="https://mumcdnstorage.blob.core.windows.net/dwnews/2018/07/cmos_biochip_module1.jpg" alt="" width="286" height="309">The current system in place for physicians to identify microbes by genetic material often involves a culturing process that can take up to weeks, creating either a delay in infection treatment or causing the physician to make an educated guess on how to treat the patient. With InSilixa’s new biochip, physicians would be able to scan a patient for microbes in under 2 hours, with no culturing required. A patient sample, such as blood or a cheek swab, is simply loaded onto a reader which then conducts 5 processes to isolate and compare genetic material to that of known pathogens.In their study published in Nature Biotechnology, the researchers claimed that their technology can identify specific mutations for antibiotic resistance in 7 different species of microbes in one run. The developers believe they will eventually be able to identify up to 100 microbes at one time. They also detected 54 mutations associated with drug resistance in 6 genes of Mycobacterium tuberculosis. The team also intends to create an open platform that allows physicians to create chips customized to scan for microbes specific to their geographic area.<iframe loading="lazy" src="https://www.youtube.com/embed/3icgDvXu1vA" width="640" height="360" frameborder="0" allowfullscreen="allowfullscreen"></iframe> 
Sources: <a href="http://www.sciencemag.org/news/2018/07/chip-can-quickly-identify-microbes-living-your-body">Science Mag</a>, <a href="https://www.nature.com/articles/Nbt.4179">Nature</a>, <a href="http://www.insilixa.com/technology/cmos-biochips/">InSilixa</a>

Lauren Dembeck, PhD

Ensifentrine Is a Novel Option for Maintenance Treatment of COPD

Pulmonology

Pam Beiler

Ferroptosis at the Forefront: The Role of Fibroblast Lipid Metabolism in IBD

Nsisong Asanga, PhD

Genetic Links Uncovered Between Iron Supplement Drug Targets and IBD

Latest News

New Chip Detects Bacteria Living in Your Body in Less Than 2 Hours

Future of Medicine

InSilixa, a biotech company based in Sunnyvale, California, has recently developed a portable device that can identify microbes present in your body in a matter of hours. The ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Diabetes

Obesity

Metabolic Care Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe